# The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant Tumor

> **NCT04405557** · — · ACTIVE_NOT_RECRUITING · sponsor: **Geneplus-Beijing Co. Ltd.** · enrollment: 757 (estimated)

## Conditions studied

- Early Detection of Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04405557
- **Lead sponsor:** Geneplus-Beijing Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-11-12
- **Primary completion:** 2022-01-16
- **Final completion:** 2026-12-31
- **Target enrollment:** 757 (ESTIMATED)
- **Last updated:** 2025-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04405557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04405557, "The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant Tumor". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04405557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*